EPFL
PeSTo: a new AI tool for predicting protein interactions
Research
EPFL
Scientists at EPFL have developed PeSTo, an AI model for predicting protein binding interfaces with proteins, nucleic acids, lipids, ions, and small molecules with high confidence. The model's low computational cost enables the processing large amounts of structural data, opening up opportunities for discovering new biology.
EPFL discovery brings us closer to next-generation electronics
Research
EPFL
EPFL engineers have found a way to control the interactions between excitons – quasiparticles that may one day transport data and replace the electrons in electronic devices. The engineers’ method involves applying an electric field to a two-dimensional (2D) semiconducting material.
New inspection drone uses wind to lengthen flight times
TechTransfer
EPFL
Elythor, an EPFL spin-off, has developed a new drone whose wing shape can adapt to wind conditions and flight position in real time, reducing the drone’s energy consumption. What’s more, the position of the wings can change, allowing the drone to fly vertically or horizontally. These features make it a perfect candidate for inspecting power plants.
Predict what a mouse sees by decoding brain signals
Research
EPFL
A research team from EPFL has developed a novel machine-learning algorithm that can reveal the hidden structure in data recorded from the brain, predicting complex information such as what mice see.
PeaceTech Alliance leverages interdisciplinarity to build peace
Politics
EPFL
EPFL, the United Nations Institute for Disarmament Research (UNIDIR), the Geneva Graduate Institute and the Geneva Peacebuilding Platform have announced the launch of a PeaceTech Alliance. It will enable collaboration on a range of Peace-to-Tech and Tech-to-Peace initiatives to contribute to the global peace agenda.
Engineering molecular interactions with machine learning
Research
EPFL
By using deep learning-generated ‘fingerprints’ to characterize millions of protein fragments, EPFL researchers have computationally designed novel protein binders that attach seamlessly to key targets, including the SARS-CoV-2 spike protein.
Page 31 of 96